Cost-effectiveness of a 21-gene recurrence score assay versus Canadian clinical practice in women with early-stage estrogen- or progesterone-receptor-positive, axillary lymph-node negative breast cancer

Peer Review reports

Original Submission
6 Dec 2011	Submitted	Original manuscript
10 Jan 2012	Reviewed	Reviewer Report - Doug Coyle
8 Mar 2012	Reviewed	Reviewer Report - Sonal Gandhi
7 May 2012	Author responded	Author comments - Malek Hannouf
Resubmission - Version 2
7 May 2012	Submitted	Manuscript version 2
27 May 2012	Reviewed	Reviewer Report - Doug Coyle
31 May 2012	Reviewed	Reviewer Report - Sonal Gandhi
30 Jul 2012	Reviewed	Reviewer Report - Chris Skedgel
21 Aug 2012	Author responded	Author comments - Malek Hannouf
Resubmission - Version 3
21 Aug 2012	Submitted	Manuscript version 3
Publishing
23 Sep 2012	Editorially accepted
2 Oct 2012	Article published	10.1186/1471-2407-12-447

Back to article page